<?xml version="1.0"?>
<doi_batch xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.crossref.org/schema/4.4.0" xmlns:fr="http://www.crossref.org/fundref.xsd" xmlns:ct="http://www.crossref.org/clinicaltrials.xsd" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" xmlns:rel="http://www.crossref.org/relations.xsd" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" version="4.4.0" xsi:schemaLocation="http://www.crossref.org/schema/4.4.0 crossref4.4.0.xsd">
  <head>
    <doi_batch_id>TODENTJ-25-03-2019_TODENTJ-8-136</doi_batch_id>
    <timestamp>1553505544</timestamp>
    <depositor>
      <depositor_name>Bentham Open</depositor_name>
      <email_address>doi@benthamopen.net</email_address>
    </depositor>
    <registrant>Bentham Open</registrant>
  </head>
  <body>
    <journal>
      <journal_metadata language="en">
        <full_title>The Open Dentistry Journal</full_title>
        <abbrev_title>TODENTJ</abbrev_title>
        <issn media_type="print">1874-2106</issn>
      </journal_metadata>
      <journal_issue>
        <publication_date media_type="print">
          <month>9</month>
          <day>8</day>
          <year>2014</year>
        </publication_date>
        <journal_volume>
          <volume>8</volume>
        </journal_volume>
        <issue>1</issue>
      </journal_issue>
      <journal_article publication_type="full_text">
        <titles>
          <title> Expression of p27Kip1 and E-cadherin in Head and Neck Squamous Cell Carcinoma of Indonesian Patients</title>
        </titles>
        <contributors>
          <person_name contributor_role="author" sequence="first">
            <given_name>Auerkari </given_name>
            <surname>E.I</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <given_name>Joewono </given_name>
            <surname>V</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <given_name>Handjari </given_name>
            <surname>D.R</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <given_name>Sarwono </given_name>
            <surname>A.T</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <given_name>Suhartono </given_name>
            <surname>A.W</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <given_name>Eto </given_name>
            <surname>K</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <given_name>Ikeda </given_name>
            <surname>M.A </surname>
          </person_name>
        </contributors>
        <jats:abstract>
                <jats:p>Cancer cells exhibit characteristic damage of DNA and its expression. The expression of the tumor suppressors E-cadherin and p27<jats:sup>Kip1</jats:sup> has been tested on 57 head and neck squamous cell carcinomas (HNSCC) of Indonesian subjects. HNSCC tumor samples including both primary and (unrelated) nodal cases were obtained from the archives of Indonesian hospitals, in accordance with acknowledged ethical requirements. Only modest correlation was found between reduced expression of E-cadherin or p27<jats:sup>Kip1</jats:sup> with increased malignancy of primary and nodal growth. The observed strong correlation regardless of malignancy between the expressed levels of E-cadherin and p27<jats:sup>Kip1</jats:sup> suggests that also in combination these would not help to better predict the outcome of HNSCC.</jats:p>
            </jats:abstract>
        <publication_date>
          <month>9</month>
          <day>8</day>
          <year>2014</year>
        </publication_date>
        <pages>
          <first_page>136</first_page>
          <last_page>143</last_page>
        </pages>
        <publisher_item>
          <identifier id_type="sici">TODENTJ-8-136</identifier>
        </publisher_item>
        <crossmark>
          <crossmark_version>1</crossmark_version>
          <crossmark_policy>10.2174/crossmark_policy</crossmark_policy>
          <crossmark_domains>
            <crossmark_domain>
              <domain>opendentistryjournal.com</domain>
            </crossmark_domain>
            <crossmark_domain>
              <domain>benthamopen.com</domain>
            </crossmark_domain>
          </crossmark_domains>
          <crossmark_domain_exclusive>true</crossmark_domain_exclusive>
          <custom_metadata>
            <assertion name="review_status" label="Review Status" group_name="peer_review_details" group_label="Peer Review Details" order="0">Peer Reviewed</assertion>
            <assertion name="review_process" label="Review Process" group_name="peer_review_details" group_label="Peer Review Details" order="1">Single blind</assertion>
            <assertion name="screening_status" label="Screening Status" group_name="plagiarism_screening" group_label="Plagiarism Screening" order="0">Checked with iThenticate</assertion>
            <assertion name="received" label="Received" group_name="publication_history" group_label="Publication History" order="0">2014-4-28</assertion>
            <assertion name="revised" label="Revised" group_name="publication_history" group_label="Publication History" order="1">2014-6-27</assertion>
            <assertion name="accepted" label="Accepted" group_name="publication_history" group_label="Publication History" order="2">2014-7-1</assertion>
            <assertion name="published" label="Published" group_name="publication_history" group_label="Publication History" order="3">2014-9-8</assertion>
            <ai:program name="AccessIndicators">
              <ai:license_ref>http://creativecommons.org/licenses/by-nc/3.0/</ai:license_ref>
            </ai:program>
          </custom_metadata>
        </crossmark>
        <doi_data>
          <doi>10.2174/1874210601408010136</doi>
          <timestamp>1553505544</timestamp>
          <resource>https://opendentistryjournal.com/VOLUME/8/PAGE/136/</resource>
          <collection property="crawler-based">
            <item crawler="google">
              <resource>https://opendentistryjournal.com/contents/volumes/V8/TODENTJ-8-136/TODENTJ-8-136.pdf</resource>
            </item>
            <item crawler="msn">
              <resource>https://opendentistryjournal.com/contents/volumes/V8/TODENTJ-8-136/TODENTJ-8-136.pdf</resource>
            </item>
            <item crawler="altavista">
              <resource>https://opendentistryjournal.com/contents/volumes/V8/TODENTJ-8-136/TODENTJ-8-136.pdf</resource>
            </item>
            <item crawler="yahoo">
              <resource>https://opendentistryjournal.com/contents/volumes/V8/TODENTJ-8-136/TODENTJ-8-136.pdf</resource>
            </item>
            <item crawler="scirus">
              <resource>https://opendentistryjournal.com/contents/volumes/V8/TODENTJ-8-136/TODENTJ-8-136.pdf</resource>
            </item>
            <item crawler="iParadigms">
              <resource>https://opendentistryjournal.com/contents/volumes/V8/TODENTJ-8-136/TODENTJ-8-136.pdf</resource>
            </item>
          </collection>
          <collection property="text-mining">
            <item>
              <resource mime_type="application/pdf">https://opendentistryjournal.com/contents/volumes/V8/TODENTJ-8-136/TODENTJ-8-136.pdf</resource>
            </item>
            <item>
              <resource mime_type="application/xml">https://opendentistryjournal.com/contents/volumes/V8/TODENTJ-8-136/TODENTJ-8-136.xml</resource>
            </item>
          </collection>
        </doi_data>
        <citation_list>
          <citation key="refR1">
            <journal_title>Nat Rev Cancer.</journal_title>
            <author>Friedl P</author>
            <volume>3</volume>
            <first_page> 362</first_page>
            <cYear>2002</cYear>
            <unstructured_citation>
            Friedl P, Wolf K. 
            Tumor-cell invasion and migration diversity and escape mechanisms. 
            Nat Rev Cancer  
            2002; 
            3
            :  362-74.
            
        </unstructured_citation>
          </citation>
          <citation key="refR2">
            <journal_title>Ann Oncol.</journal_title>
            <author>Boyle P</author>
            <volume>16</volume>
            <first_page> 481</first_page>
            <cYear>2005</cYear>
            <unstructured_citation>
            Boyle P, Ferlay J. 
            Cancer incidence and mortality in Europe, 2004,. 
            Ann Oncol  
            2005; 
            16
            :  481-8.
            
        </unstructured_citation>
          </citation>
          <citation key="refR3">
            <journal_title>Ann Oncol.</journal_title>
            <author>Bosetti C</author>
            <volume>16</volume>
            <first_page> 489</first_page>
            <cYear>2005</cYear>
            <unstructured_citation>
            Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. 
            Trends in cancer mortality in the Americas, 1970,-2000,. 
            Ann Oncol  
            2005; 
            16
            :  489-511.
            
        </unstructured_citation>
          </citation>
          <citation key="refR4">
            <journal_title>Nature Rev Cancer.</journal_title>
            <author>Hunter KD</author>
            <volume>5</volume>
            <first_page> 127</first_page>
            <cYear>2005</cYear>
            <unstructured_citation>
            Hunter KD,  Parkinson EK,  Harrison PR. 
            Profiling early head and neck cancer. 
            Nature Rev Cancer  
            2005; 
            5
            :  127-35.
            
        </unstructured_citation>
          </citation>
          <citation key="refR5">
            <journal_title>Crit Rev Oral Biol Med.</journal_title>
            <author>Wong DTW</author>
            <volume>7</volume>
            <first_page> 319</first_page>
            <cYear>1996</cYear>
            <unstructured_citation>
            Wong DTW, Todd R, Tsuji T, Donoff RB. 
            Molecular biology of human oral cancer. 
            Crit Rev Oral Biol Med  
            1996; 
            7
            (4)
            :  319-28.
            
        </unstructured_citation>
          </citation>
          <citation key="refR6">
            <journal_title>Scand J Dent Res.</journal_title>
            <author>Anneroth G</author>
            <volume>95</volume>
            <first_page> 229</first_page>
            <cYear>1987</cYear>
            <unstructured_citation>
            Anneroth G, Batsakis J, Luna M. 
            Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. 
            Scand J Dent Res  
            1987; 
            95
            :  229-48.
            
        </unstructured_citation>
          </citation>
          <citation key="refR7">
            <journal_title>Nature.</journal_title>
            <author>Venkitaraman AR</author>
            <volume>434</volume>
            <first_page> 829</first_page>
            <cYear>2005</cYear>
            <unstructured_citation>
            Venkitaraman AR. 
            Aborting the birth of cancer. 
            Nature  
            2005; 
            434
            :  829-30.
            
        </unstructured_citation>
          </citation>
          <citation key="refR8">
            <journal_title> Nature Genet.</journal_title>
            <author>Roepman P</author>
            <volume>37</volume>
            <first_page> 182</first_page>
            <cYear>2005</cYear>
            <unstructured_citation>
            Roepman P, Wessels LF A, Kettelarij N , et al. 
            Holstege F.C. P. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. 
             Nature Genet  
            2005; 
            37
            :  182-6.
            
        </unstructured_citation>
          </citation>
          <citation key="refR9">
            <journal_title>Cancer.</journal_title>
            <author>Mineta H</author>
            <volume>85</volume>
            <first_page> 1011</first_page>
            <cYear>1999</cYear>
            <unstructured_citation>
            Mineta H, Miura K, Suzuki I , et al. 
            Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. 
            Cancer  
            1999; 
            85
            (5)
            :  1011-7.
            
        </unstructured_citation>
          </citation>
          <citation key="refR10">
            <journal_title>Cancer.</journal_title>
            <author>Takata T</author>
            <volume>86</volume>
            <first_page> 928</first_page>
            <cYear>1999</cYear>
            <unstructured_citation>
            Takata T, Kudo Y, Zhao M , et al. 
            Reduced expression of p27Kip1 protein in relation to salivary adenoid cyctic carcinoma metastasis. 
            Cancer  
            1999; 
            86
            (6)
            :  928-35.
            
        </unstructured_citation>
          </citation>
          <citation key="refR11">
            <journal_title>Nature Cell Biol.</journal_title>
            <author>Bartek J</author>
            <volume>3</volume>
            <first_page> E95</first_page>
            <cYear>2001</cYear>
            <unstructured_citation>
            Bartek J, Lukas J. 
            p27 destruction Cks1 pulls the trigger. 
            Nature Cell Biol  
            2001; 
            3
            :  E95-8.
            
        </unstructured_citation>
          </citation>
          <citation key="refR12">
            <journal_title>Cancer.</journal_title>
            <author>Oka K</author>
            <volume>88</volume>
            <first_page> 2766</first_page>
            <cYear>2000</cYear>
            <unstructured_citation>
            Oka K, Suzuki Y, Nakano T. 
            Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone. 
            Cancer  
            2000; 
            88
            (12)
            :  2766-73.
            
        </unstructured_citation>
          </citation>
          <citation key="refR13">
            <journal_title>Int J Cancer.</journal_title>
            <author>Yao J</author>
            <volume>89</volume>
            <first_page> 213</first_page>
            <cYear>2000</cYear>
            <unstructured_citation>
            Yao J, Eu KW,  Seow-Choen F, Cheah PY. 
            Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas. 
            Int J Cancer  
            2000; 
            89
            :  213-6.
            
        </unstructured_citation>
          </citation>
          <citation key="refR14">
            <journal_title>Laryngoscope.</journal_title>
            <author>Fan GK</author>
            <volume>109</volume>
            <first_page> 815</first_page>
            <cYear>1999</cYear>
            <unstructured_citation>
            Fan GK,  Fujieda S, Sunaga H, Tsuzuki H, Ito N, Saito H. 
            Expression of protein p27 is associated with progression and prognosis in laryngeal cancer. 
            Laryngoscope  
            1999; 
            109
            :  815-20.
            
        </unstructured_citation>
          </citation>
          <citation key="refR15">
            <journal_title>Amer J Pathol.</journal_title>
            <author>Florenes VA</author>
            <volume>153</volume>
            <first_page> 305</first_page>
            <cYear>1998</cYear>
            <unstructured_citation>
            Florenes VA,  Maelandsmo GM,  Kerbel RS,  Slingerland JM,  Nesland JM,  Holm R. 
            Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma. 
            Amer J Pathol  
            1998; 
            153
            (1)
            :  305-12.
            
        </unstructured_citation>
          </citation>
          <citation key="refR16">
            <journal_title>Cancer.</journal_title>
            <author>Feakins RM</author>
            <volume>89</volume>
            <first_page> 1684</first_page>
            <cYear>2000</cYear>
            <unstructured_citation>
            Feakins RM,  Mulcahy HE,  Quaglia A, Jawhari A, Zhang Z, Patchett SE. 
            p27Kip1 loss does not predict survival in patients with advanced gastric carcinoma. 
            Cancer  
            2000; 
            89
            :  1684-91.
            
        </unstructured_citation>
          </citation>
          <citation key="refR17">
            <journal_title>J Cell Biol.</journal_title>
            <author>St.Croix B</author>
            <volume>142</volume>
            <first_page> 557</first_page>
            <cYear>1998</cYear>
            <unstructured_citation>
            St.Croix B, Sheehan C, Rak JW,  Florenes VA,  Slingerland JM,  Kerbel RS. 
            E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27Kip1. 
            J Cell Biol  
            1998; 
            142
            (2)
            :  557-71.
            
        </unstructured_citation>
          </citation>
          <citation key="refR18">
            <journal_title>J Pathol.</journal_title>
            <author>Takes RP</author>
            <volume>194</volume>
            <first_page> 298</first_page>
            <cYear>2001</cYear>
            <unstructured_citation>
            Takes RP,  Baatenburg de Jong RJ,  Wijffels K , et al. 
            Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. 
            J Pathol  
            2001; 
            194
            :  298-302.
            
        </unstructured_citation>
          </citation>
          <citation key="refR19">
            <journal_title>J Cell Biol.</journal_title>
            <author>Hermisto  ML</author>
            <volume>129</volume>
            <first_page> 489</first_page>
            <cYear>1995</cYear>
            <unstructured_citation>
            Hermisto  ML, Gordon JI. 
            In vivo analysis of cadherin function in the mouse intestinal epithelium essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. 
            J Cell Biol  
            1995; 
            129
            (2)
            :  489-506.
            
        </unstructured_citation>
          </citation>
          <citation key="refR20">
            <journal_title>Oncogene.</journal_title>
            <author>Berx G</author>
            <volume>13</volume>
            <first_page> 1919</first_page>
            <cYear>1996</cYear>
            <unstructured_citation>
            Berx G, Cleton-Jansen AM,  Strumane K , et al. 
            E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. 
            Oncogene  
            1996; 
            13
            :  1919-25.
            
        </unstructured_citation>
          </citation>
          <citation key="refR21">
            <journal_title>Int J Cancer.</journal_title>
            <author>Woo DK</author>
            <volume>95</volume>
            <first_page> 108</first_page>
            <cYear>2001</cYear>
            <unstructured_citation>
            Woo DK,  Kim HK,  Lee HS,  Kang YH,  Yang HK,  Kim WH. 
            Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines. 
            Int J Cancer  
            2001; 
            95
            :  108-13.
            
        </unstructured_citation>
          </citation>
        </citation_list>
      </journal_article>
    </journal>
  </body>
</doi_batch>
